Pages that link to "Q37702962"

The following pages link to Role of bone morphogenetic protein receptors in the development of pulmonary arterial hypertension (Q37702962):

Displaying 29 items.

• Reconstructing sickle cell disease: A data‐based analysis of the “hyperhemolysis paradigm” for pulmonary hypertension from the perspective of evidence‐based medicine (Q33803027) (← links)
• Subcellular mechanisms in pulmonary arterial hypertension: combinatorial modalities that inhibit anterograde trafficking and cause bone morphogenetic protein receptor type 2 mislocalization (Q33806134) (← links)
• Obliterative airway remodeling: molecular evidence for shared pathways in transplanted and native lungs (Q33808050) (← links)
• Decreased Neprilysin and Pulmonary Vascular Remodeling in Chronic Obstructive Pulmonary Disease (Q34665155) (← links)
• The role of autophagy in vascular biology (Q35037113) (← links)
• Protein trafficking dysfunctions: Role in the pathogenesis of pulmonary arterial hypertension (Q35412349) (← links)
• Abnormal expression of NSF, α-SNAP and SNAP23 in pulmonary arterial hypertension in rats treated with monocrotaline (Q35479468) (← links)
• Eps15R is required for bone morphogenetic protein signalling and differentially compartmentalizes with Smad proteins (Q36037484) (← links)
• Identification of Biomarkers for Schistosoma-Associated Pulmonary Arterial Hypertension Based on RNA-Seq Data of Mouse Whole Lung Tissues (Q36341659) (← links)
• Hypothesis: neuroendocrine mechanisms (hypothalamus-growth hormone-STAT5 axis) contribute to sex bias in pulmonary hypertension (Q36568290) (← links)
• Signal transduction in the development of pulmonary arterial hypertension (Q37133785) (← links)
• Augmented noncanonical BMP type II receptor signaling mediates the synaptic abnormality of fragile X syndrome. (Q37611383) (← links)
• TGFβ signaling and cardiovascular diseases (Q37976673) (← links)
• Rho GTPases in pulmonary vascular dysfunction (Q38043896) (← links)
• STAT3 regulation of and by microRNAs in development and disease (Q38140887) (← links)
• Signaling by the TGFβ superfamily (Q38148526) (← links)
• Herpes simplex virus is equipped with RNA- and protein-based mechanisms to repress expression of ATRX, an effector of intrinsic immunity. (Q39316080) (← links)
• The first Keystone Symposia Conference on pulmonary vascular isease and right ventricular dysfunction: Current concepts and future therapies (Q39353707) (← links)
• Abnormal expression of vesicular transport proteins in pulmonary arterial hypertension in monocrotaline-treated rats (Q41513099) (← links)
• Negative autoregulation of BMP dependent transcription by SIN3B splicing reveals a role for RBM39. (Q41833592) (← links)
• Commentary: Bone morphogenetic protein's contribution to pulmonary artery hypertension: Should this raise concern for patients undergoing spinal fusions with bone morphogenetic protein? (Q42107940) (← links)
• Clinical significance linked to functional defects in bone morphogenetic protein type 2 receptor, BMPR2. (Q42332006) (← links)
• Hungry for more: autophagy in the pathogenesis of pulmonary arterial hypertension (Q43067570) (← links)
• Metabolic Dysfunction in the Pathogenesis of Pulmonary Hypertension (Q44405403) (← links)
• Bone morphogenetic protein-5 and early endothelial outgrowth cells (eEOCs) in acute ischemic kidney injury (AKI) and 5/6-chronic kidney disease (Q44607761) (← links)
• cGMP and PKGI are required for vascular BMP signaling. (Q45928914) (← links)
• Intra-Amniotic Soluble Endoglin Impairs Lung Development in Neonatal Rats. (Q47869716) (← links)
• Epsin15 Homology Domains: Role in the Pathogenesis of Pulmonary Arterial Hypertension (Q58586942) (← links)
• Rho signaling pathway enhances proliferation of PASMCs by suppressing nuclear translocation of Smad1 in PAH. (Q64881402) (← links)